199
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Measurement of maternal serum amyloid A as a novel marker of preterm birth

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 2467-2472 | Received 15 Jan 2019, Accepted 12 Sep 2019, Published online: 25 Sep 2019

References

  • Haram K, Mortensen JH, Wollen AL. Preterm delivery: an overview. Acta Obstet Gynecol Scand. 2003;82(8):687–704.
  • Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Org. 2010;88(1):31–38.
  • Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
  • Berkman ND, Thorp JM Jr, Hartmann KE, et al. Management of preterm labor. Summary, Evidence Report/Technology Assessment: Number 18. AHRQ Publication No. 01-E020. 2000. Rockville (MD): Agency for Healthcare Research and Quality. p. 1–6.
  • Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 1993;102(2):131–146.
  • Köseoğlu SB, Guzel AI, Deveer R, et al. Maternal serum amyloid A levels in pregnancies complicated with preterm prelabour rupture of membranes. Ginekol Pol. 2014;85(7):516–520.
  • Hagihara K, Nishikawa T, Isobe T, et al. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun. 2004;314(2):363–369.
  • Ibrahim MI, Ramy AR, Abdelhamid AS, et al. Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss. Int J Gynecol Obstet. 2017;136(3):298–303.
  • American College of Obstetricians and Gynecologists, Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 127: management of preterm labor. Obstet Gynecol. 2012;119(6):1308–1317.
  • Lannergård A, Larsson A, Kragsbjerg P, et al. Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest. 2003;63(4):267–272.
  • Yang Q, Whitin JC, Ling XB, et al. Plasma biomarkers in a mouse model of preterm labor. Pediatr Res. 2009;66(1):11–16.
  • Kim YH, Park YW, Cho DJ, et al. Usefulness of maternal serum amyloid A as a predictor of tocolytic failure in preterm delivery. Korean J Obstet Gynecol. 2004;47:1653–4661.
  • Çekmez Y, Çekmez F, Özkaya E, et al. Proadrenomedullin and serum amyloid A as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes. J Interferon Cytokine Res. 2013;33(11):694–699.
  • Ostensen M, Marhaug G, Husby G. Amyloid-related serum protein (SAA) during and after pregnancy in healthy women and women with rheumatic disease. Acta Pathol Microbiol Immunol Scand C. 1985;93(1):1–5.
  • Cicarelli LM, Perroni AG, Zugaib M, et al. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery. Mediators Inflamm. 2005;2005(2):96–100.
  • de Villiers WJ, Louw JP, Strachan AF, et al. C-reactive protein and serum amyloid A protein in pregnancy and labour. BJOG. 1990;97(8):725–730.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.